Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Assessment of platelet function assays

N S Nicholson1, S G Panzer-Knodle, N F Haas

  • 1Thrombosis Research Group, Searle, Skokie, Ill 60077, USA.

American Heart Journal
|May 20, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of nerve growth factor-induced mechanical and thermal hypersensitivity in rats.

European journal of pain (London, England)·2012
Same author

Characterization of Binding of an RGD Mimetic, [(3)H]-SC-52012, to Platelet GPIIb/IIIa.

Platelets·2010
Same author

Leprosy in Canada.

Canadian Medical Association journal·2010
Same author

In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models.

British journal of pharmacology·2007
Same author

The role of tissue factor/factor VIIa in the pathophysiology of acute thrombotic formation.

Current opinion in pharmacology·2001
Same author

Ternary complexes of liver alcohol dehydrogenase.

Chemico-biological interactions·2001
Same journal

Stratified Medicine with Eplerenone for Myocardial Infarction or Injury and No obstructive Coronary Arteries: A Registry-Based Basket Trial.

American heart journal·2026
Same journal

Revised Lipid-Lowering Therapy Guidelines in a Nationally Representative Sample.

American heart journal·2026
Same journal

Cardiometabolic Health of Low- and Higher-Income Adults in the United States, 2009-2023.

American heart journal·2026
Same journal

Moving Beyond Technical Capability to Regulatory Integration for Digital Health Technology Devices-Brief Communication from the Cardiovascular Sciences Research Consortium.

American heart journal·2026
Same journal

THE SOCIETY OF CRITICAL CARE CARDIOLOGY - RATIONALE, BLUEPRINT, AND LESSONS LEARNED IN THE CREATION OF A NEW MULTIDISCIPLINARY PROFESSIONAL ORGANIZATION.

American heart journal·2026
Same journal

DOAC Score Among Patients Receiving Vitamin K Antagonists.

American heart journal·2026
See all related articles

Optical aggregometry shows significant variability due to sample preparation and technical factors. Day-to-day and within-assay variations are major contributors, impacting platelet function test reliability.

Area of Science:

  • Hematology
  • Clinical Chemistry

Background:

  • Optical aggregometry is a standard method for assessing platelet function.
  • This technique is sensitive to sample preparation and procedural variations, leading to inter-laboratory data discrepancies.

Purpose of the Study:

  • To identify and quantify sources of variation in optical aggregometry.
  • To evaluate alternative platelet function assays for improved reliability.

Main Methods:

  • Analysis of total standard deviation, assay variation, day-to-day variation, between-operator variation, and within-operator variation.
  • Comparison of optical aggregometry with alternative assays: activated clotting time, whole blood aggregometry, platelet count ratio, Platelet Function Analyzer (PFA-100), and Rapid Platelet Function Assay (RPFA).

Related Experiment Videos

Main Results:

  • Total standard deviation for optical aggregometry ranged from 3.6% to 7.7%.
  • Day-to-day variation accounted for 42% to 63% of total variation.
  • Alternative assays were evaluated for their relation to coagulation and platelet function.

Conclusions:

  • Optical aggregometry exhibits substantial variability, primarily driven by day-to-day and within-assay factors.
  • Alternative assays like PFA-100 and whole blood aggregometry offer different insights into hemostasis and platelet function.
  • Clinical trials are necessary to determine the optimal assay for monitoring antiplatelet therapies.